Stereotaxis, Inc. Common Stock (STXS) — Analysis Summary
Stereotaxis, Inc. Common Stock (STXS) has a market cap of $128.52M with year-over-year revenue growth of +20.3%. Net margin stands at -66.8%. The stock trades at a P/E ratio of -5.9.
Key Takeaways
- Revenue changed +20.3% year-over-year
- Net margin of -66.8%
- P/E ratio of -5.9
Compared to other companies in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector, STXS posted revenue growth of +20.3% and trades at a P/E of -5.9.
Stereotaxis, Inc. Common Stock (STXS)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -45.6x — earnings do not cover interest payments
Operating margin at -71.0% — severe operating losses
Net margin at -69.5% — significant losses
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Sector
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees
131
Headquarters
ST.LOUIS, MO
Exchange
XASE
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.